How does Clopidogrel impact C-reactive protein levels in patients with inflammatory cardiovascular diseases, and what significance does this have for clinical outcomes?
Sahil KapoorExplorer
How does Clopidogrel impact C-reactive protein levels in inflammatory cardiovascular diseases?
Share
Clopidogrel can reduce C-reactive protein levels in cardiovascular disease, potentially lowering inflammation and improving clinical outcomes such as reducing the risk of recurrent cardiovascular events.